Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01726114 · ClinicalTrials.gov registry record · NA

A Clinical Study of the C8 MediSensors Optical Glucose Monitor™

A NA study of Diabetes Mellitus, sponsored by C8 MediSensors.

Completed
Registry status
NA
Development phase
86
Enrollment target
1
Study location

NCT01726114: Completed NA study of Diabetes Mellitus, sponsored by C8 MediSensors.

NCT01726114 is a NA study of Diabetes Mellitus that has completed, run by C8 MediSensors. The registered enrollment target is 86 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01726114, a NA study of Diabetes Mellitus, has completed, sponsored by C8 MediSensors.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare glucose measurements from the C8 MediSensors non-invasive Optical Glucose Monitor™ System to blood glucose measurements from the Yellow Springs Instrument(YSI) blood glucose analyzer.

Primary Outcome

The primary objective is to characterize the accuracy of the non-invasive glucose measurements from the Optical Glucose Monitor™ to blood glucose measurements on a sample size of approximately 30 subjects with 1000 time matched, paired data points.

Conditions Studied

Diabetes Mellitus

Interventions

  • DEVICE Non-invasive Optical Glucose Monitor™
  • DEVICE YSI blood glucose analyzer

Study Locations (1)

California

  • C8 MediSensors, Inc. - San Jose

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2012-06
Est. Completion 2013-03
Phase NA
C8 MediSensors

1 total trials

What the finished NCT01726114 record still lists

NCT01726114 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Non-invasive Optical Glucose Monitor™ is the first listed.

NCT01726114 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01726114 about?

NCT01726114 is a clinical study titled "A Clinical Study of the C8 MediSensors Optical Glucose Monitor™". The purpose of this study is to compare glucose measurements from the C8 MediSensors non-invasive Optical Glucose Monitor™ System to blood glucose measurements from the Yellow Springs Instrument(YSI) blood glucose analyzer.

What is the current status of trial NCT01726114?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2012-06. Estimated completion is 2013-03.

What conditions does trial NCT01726114 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT01726114?

The interventions under investigation include: Non-invasive Optical Glucose Monitor™ (DEVICE), YSI blood glucose analyzer (DEVICE).

Who is sponsoring clinical trial NCT01726114?

This trial is sponsored by C8 MediSensors, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01726114 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01726114's enrollment target sits among peer trials

86 128th of 208 higher than 80 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01639508 · 86 participants · Phase 2

    Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

  • NCT03519269 · 86 participants · NA

    Navio Robotic Versus Conventional Total Knee Arthroplasty

  • NCT04132999 · 86 participants · NA

    PAP for Children With DS and OSAS

  • NCT04545957 · 86 participants · NA

    Jump: MR Simulation For Radiation Therapy Master Protocol

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01726114, the US trial registry maintained by the National Library of Medicine. NCT01726114 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.